Branded Generics - Global 麻豆原创 Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Publication ID:

PB509245121

Publication Date:

September 16, 2024

Pages:

100

Publisher:

MRRPB5

Countries:

Global [1]

USD 3,950.00

Healthcare [2]

Pharma & Healthcare [3]

Description:

This report mainly focuses on branded generics market. Branded generics are generic drugs that have been given a proprietary market name. They may be marketed similarly to how branded drugs are. Branded generic drugs attach proprietary names to generic drug molecules.听
The global market for Branded Generics was estimated to be worth US$ 312 million in 2023 and is forecast to a readjusted size of US$ 523.1 million by 2030 with a CAGR of 8.2% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Branded Generics, focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Branded Generics by region & country, by Type, and by Application.
The Branded Generics market size, estimations, and forecasts are provided in terms of sales volume (K MT) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Branded Generics.
麻豆原创 Segmentation
By Company
Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health
Segment by Type:
Oral
Parenteral
Topical
Other
Segment by Application
Oncology
Cardiovascular Diseases
Diabetes
Neurology
Gastrointestinal Diseases
Others
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
U.A.E
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Branded Generics manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Branded Generics in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Branded Generics in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.

Table Of Contents:

1 麻豆原创 Overview
1.1 Branded Generics Product Introduction
1.2 Global Branded Generics 麻豆原创 Size Forecast
1.2.1 Global Branded Generics Sales Value (2019-2030)
1.2.2 Global Branded Generics Sales Volume (2019-2030)
1.2.3 Global Branded Generics Sales Price (2019-2030)
1.3 Branded Generics 麻豆原创 Trends & Drivers
1.3.1 Branded Generics Industry Trends
1.3.2 Branded Generics 麻豆原创 Drivers & Opportunity
1.3.3 Branded Generics 麻豆原创 Challenges
1.3.4 Branded Generics 麻豆原创 Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Branded Generics Players Revenue Ranking (2023)
2.2 Global Branded Generics Revenue by Company (2019-2024)
2.3 Global Branded Generics Players Sales Volume Ranking (2023)
2.4 Global Branded Generics Sales Volume by Company Players (2019-2024)
2.5 Global Branded Generics Average Price by Company (2019-2024)
2.6 Key Manufacturers Branded Generics Manufacturing Base Distribution and Headquarters
2.7 Key Manufacturers Branded Generics Product Offered
2.8 Key Manufacturers Time to Begin Mass Production of Branded Generics
2.9 Branded Generics 麻豆原创 Competitive Analysis
2.9.1 Branded Generics 麻豆原创 Concentration Rate (2019-2024)
2.9.2 Global 5 and 10 Largest Manufacturers by Branded Generics Revenue in 2023
2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Branded Generics as of 2023)
2.10 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Oral
3.1.2 Parenteral
3.1.3 Topical
3.1.4 Other
3.2 Global Branded Generics Sales Value by Type
3.2.1 Global Branded Generics Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Branded Generics Sales Value, by Type (2019-2030)
3.2.3 Global Branded Generics Sales Value, by Type (%) (2019-2030)
3.3 Global Branded Generics Sales Volume by Type
3.3.1 Global Branded Generics Sales Volume by Type (2019 VS 2023 VS 2030)
3.3.2 Global Branded Generics Sales Volume, by Type (2019-2030)
3.3.3 Global Branded Generics Sales Volume, by Type (%) (2019-2030)
3.4 Global Branded Generics Average Price by Type (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Oncology
4.1.2 Cardiovascular Diseases
4.1.3 Diabetes
4.1.4 Neurology
4.1.5 Gastrointestinal Diseases
4.1.6 Others
4.2 Global Branded Generics Sales Value by Application
4.2.1 Global Branded Generics Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Branded Generics Sales Value, by Application (2019-2030)
4.2.3 Global Branded Generics Sales Value, by Application (%) (2019-2030)
4.3 Global Branded Generics Sales Volume by Application
4.3.1 Global Branded Generics Sales Volume by Application (2019 VS 2023 VS 2030)
4.3.2 Global Branded Generics Sales Volume, by Application (2019-2030)
4.3.3 Global Branded Generics Sales Volume, by Application (%) (2019-2030)
4.4 Global Branded Generics Average Price by Application (2019-2030)
5 Segmentation by Region
5.1 Global Branded Generics Sales Value by Region
5.1.1 Global Branded Generics Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Branded Generics Sales Value by Region (2019-2024)
5.1.3 Global Branded Generics Sales Value by Region (2025-2030)
5.1.4 Global Branded Generics Sales Value by Region (%), (2019-2030)
5.2 Global Branded Generics Sales Volume by Region
5.2.1 Global Branded Generics Sales Volume by Region: 2019 VS 2023 VS 2030
5.2.2 Global Branded Generics Sales Volume by Region (2019-2024)
5.2.3 Global Branded Generics Sales Volume by Region (2025-2030)
5.2.4 Global Branded Generics Sales Volume by Region (%), (2019-2030)
5.3 Global Branded Generics Average Price by Region (2019-2030)
5.4 North America
5.4.1 North America Branded Generics Sales Value, 2019-2030
5.4.2 North America Branded Generics Sales Value by Country (%), 2023 VS 2030
5.5 Europe
5.5.1 Europe Branded Generics Sales Value, 2019-2030
5.5.2 Europe Branded Generics Sales Value by Country (%), 2023 VS 2030
5.6 Asia Pacific
5.6.1 Asia Pacific Branded Generics Sales Value, 2019-2030
5.6.2 Asia Pacific Branded Generics Sales Value by Country (%), 2023 VS 2030
5.7 South America
5.7.1 South America Branded Generics Sales Value, 2019-2030
5.7.2 South America Branded Generics Sales Value by Country (%), 2023 VS 2030
5.8 Middle East & Africa
5.8.1 Middle East & Africa Branded Generics Sales Value, 2019-2030
5.8.2 Middle East & Africa Branded Generics Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Branded Generics Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Branded Generics Sales Value
6.2.1 Key Countries/Regions Branded Generics Sales Value, 2019-2030
6.2.2 Key Countries/Regions Branded Generics Sales Volume, 2019-2030
6.3 United States
6.3.1 United States Branded Generics Sales Value, 2019-2030
6.3.2 United States Branded Generics Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Branded Generics Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Branded Generics Sales Value, 2019-2030
6.4.2 Europe Branded Generics Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Branded Generics Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Branded Generics Sales Value, 2019-2030
6.5.2 China Branded Generics Sales Value by Type (%), 2023 VS 2030
6.5.3 China Branded Generics Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Branded Generics Sales Value, 2019-2030
6.6.2 Japan Branded Generics Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Branded Generics Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Branded Generics Sales Value, 2019-2030
6.7.2 South Korea Branded Generics Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Branded Generics Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Branded Generics Sales Value, 2019-2030
6.8.2 Southeast Asia Branded Generics Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Branded Generics Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Branded Generics Sales Value, 2019-2030
6.9.2 India Branded Generics Sales Value by Type (%), 2023 VS 2030
6.9.3 India Branded Generics Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Mylan NV
7.1.1 Mylan NV Company Information
7.1.2 Mylan NV Introduction and Business Overview
7.1.3 Mylan NV Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.1.4 Mylan NV Branded Generics Product Offerings
7.1.5 Mylan NV Recent Development
7.2 Novartis AG
7.2.1 Novartis AG Company Information
7.2.2 Novartis AG Introduction and Business Overview
7.2.3 Novartis AG Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.2.4 Novartis AG Branded Generics Product Offerings
7.2.5 Novartis AG Recent Development
7.3 Eva Pharmaceutical Industries
7.3.1 Eva Pharmaceutical Industries Company Information
7.3.2 Eva Pharmaceutical Industries Introduction and Business Overview
7.3.3 Eva Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.3.4 Eva Pharmaceutical Industries Branded Generics Product Offerings
7.3.5 Eva Pharmaceutical Industries Recent Development
7.4 Pfizer
7.4.1 Pfizer Company Information
7.4.2 Pfizer Introduction and Business Overview
7.4.3 Pfizer Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.4.4 Pfizer Branded Generics Product Offerings
7.4.5 Pfizer Recent Development
7.5 Sun Pharmaceutical Industries
7.5.1 Sun Pharmaceutical Industries Company Information
7.5.2 Sun Pharmaceutical Industries Introduction and Business Overview
7.5.3 Sun Pharmaceutical Industries Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.5.4 Sun Pharmaceutical Industries Branded Generics Product Offerings
7.5.5 Sun Pharmaceutical Industries Recent Development
7.6 Aspen Pharmacare Holding
7.6.1 Aspen Pharmacare Holding Company Information
7.6.2 Aspen Pharmacare Holding Introduction and Business Overview
7.6.3 Aspen Pharmacare Holding Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.6.4 Aspen Pharmacare Holding Branded Generics Product Offerings
7.6.5 Aspen Pharmacare Holding Recent Development
7.7 Abbott Laboratories
7.7.1 Abbott Laboratories Company Information
7.7.2 Abbott Laboratories Introduction and Business Overview
7.7.3 Abbott Laboratories Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.7.4 Abbott Laboratories Branded Generics Product Offerings
7.7.5 Abbott Laboratories Recent Development
7.8 Bausch Health
7.8.1 Bausch Health Company Information
7.8.2 Bausch Health Introduction and Business Overview
7.8.3 Bausch Health Branded Generics Sales, Revenue and Gross Margin (2019-2024)
7.8.4 Bausch Health Branded Generics Product Offerings
7.8.5 Bausch Health Recent Development
8 Industry Chain Analysis
8.1 Branded Generics Industrial Chain
8.2 Branded Generics Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Branded Generics Sales Model
8.5.2 Sales Channel
8.5.3 Branded Generics Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer

Companies Mentioned:

Mylan NV
Novartis AG
Eva Pharmaceutical Industries
Pfizer
Sun Pharmaceutical Industries
Aspen Pharmacare Holding
Abbott Laboratories
Bausch Health

License Types:

Single User License (PDF)

This license allows for use of a publication by one person.
This person may print out a single copy of the publication.
This person can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
This person cannot share the publication (or any information contained therein) with any other person or persons.
Unless a Enterprise License is purchased, a Single User License must be purchased for every person that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Site License (PDF)*

This license allows for use of a publication by all users within one corporate location, e.g. a regional office.
These users may print out a single copy of the publication.
These users can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.
These users cannot share the publication (or any information contained therein) with any other person or persons outside the corporate location for which the publication is purchased.
Unless a Enterprise License is purchased, a Site User License must be purchased for every corporate location by an organization that wishes to use the publication within the same organization.
Customers who infringe these license terms are liable for a Global license fee.

听

Global License (PDF)*

This license allows for use of a publication by unlimited users within the purchasing organization e.g. all employees of a single company.
Each of these people may use the publication on any computer, and may print out the report, but may not share the publication (or any information contained therein) with any other person or persons outside of the organization.
These employees of purchasing organization can include information given in the publication in presentations and internal reports by providing full copyright credit to the publisher.

*If Applicable.